Journey Medical Corp
在场
Journey Medical Corp 的所有者是 Fortress Biotech.
Fortress Biotech 是一家在股票代码 FBIO (US) 下上市的公司。
Fortress Biotech 拥有 4家子公司，其中包括 Avenue Therapeutics、Checkpoint Therapeutics 和 Journey Medical Corp。
他们在：
高管
查看带有其 14 名主要高管的组织结构图
Journey Medical Corp 搜索最多的简介
- Claude Maraoui, Director, President and Chief Executive Officer
- Justin Smith, Director
- Michael Pearce, Director
高管在Journey Medical Corp变化
- Michael Pearce已作为Director加入公司 (新闻发布的2024七月12号).
- Joseph Benesch 曾任 Interim Chief Financial Officer, 现升职为 Chief Financial Officer (新闻发布的2024五月2号).
创建提醒
跟踪 Journey Medical Corp 的高管变动
基金
Fortress Biotech 拥有 1,524 家竞争者，其中包括 BlackRock (美国(美洲))、Blackstone Group (美国(美洲)) 和 Vanguard (美国(美洲))。
Popular M&A news in 基金
- RIV Capital and Cansortium have announced they will merge (公布2024十月14号)..
- Janus Henderson Group 已收购 Victory Park Capital (公布2024十月7号).
- General Atlantic 已收购 Actis (公布2024十月3号).
基金 行业的其他推荐联系人
消息
Journey Medical Corp 的最新新闻稿
- Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
- Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
- Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea
- Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference
- Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
- Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference
- Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
- Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024
- Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
- View more press releases Close
通过电子邮件
